Foodborne botulism: an international outbreak. 1989

P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
Department of Epidemiology, Ministry of Health, Jerusalem, Israel.

We report an outbreak of fishborne botulism caused by type E Clostridium botulinum. The eight cases, six in Israel and two in New York City, resulted from the consumption of ribbetz or kapchunka, a freshwater whitefish soaked in brine and air-dried, that was processed commercially in New York. Half the cases were males; the age range was 9 to 77 years. Five of the victims were hospitalized; the oldest died, and two others required ventilatory assistance. Laboratory confirmation of botulism was obtained in three cases. Prolonged lack of refrigeration during transatlantic flight and packaging contributing to an anaerobic environment were felt to be contributing environmental factors in the Israeli cases. Rapid communication and full cooperation between Israeli and US health authorities limited the extent of the outbreak. Despite adequate understanding of how foodborne botulism may be avoided, outbreaks still occur, particularly among people consuming certain high-risk or ethnic foods.

UI MeSH Term Description Entries
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D001904 Botulinum Antitoxin Antiserum given therapeutically in BOTULISM. Botulism Antitoxin,Trivalent Equine Botulinum Antitoxin,Antitoxin, Botulinum,Antitoxin, Botulism
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D001906 Botulism A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208) Botulism, Infantile,Botulism, Toxico-Infectious,Clostridium botulinum Infection,Foodborne Botulism,Infant Botulism,Toxico-Infectious Botulism,Wound Botulism,Botulism, Foodborne,Botulism, Infant,Botulism, Toxico Infectious,Botulism, Wound,Clostridium botulinum Infections,Foodborne Botulisms,Infant Botulisms,Infantile Botulism,Infection, Clostridium botulinum,Toxico Infectious Botulism,Wound Botulisms
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D005260 Female Females

Related Publications

P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
January 2009, International journal of hygiene and environmental health,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
July 2003, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
February 2014, Medicina clinica,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
June 1990, Epidemiology and infection,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
January 2013, Japanese journal of infectious diseases,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
June 2024, Saudi medical journal,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
December 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
August 1992, BMJ (Clinical research ed.),
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
November 1981, FDA drug bulletin,
P E Slater, and D G Addiss, and A Cohen, and A Leventhal, and G Chassis, and H Zehavi, and A Bashari, and C Costin
December 1988, International journal of epidemiology,
Copied contents to your clipboard!